• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1986 - 1995年哥本哈根县腮腺良性肿瘤]

[Benign neoplasms in the parotid gland in the county of Copenhagen 1986-1995].

作者信息

Christensen N R, Charabi S, Sørensen W T, Dethloff T, Balle V H, Tos M

机构信息

Amtssygehuset i Gentofte, afdelingen for otolaryngologi.

出版信息

Ugeskr Laeger. 1998 Oct 12;160(42):6066-9.

PMID:9800509
Abstract

In a ten year period from 1986-95 433 patients were submitted to operation due to benign tumours in the parotid gland in Copenhagen County. In this study we made a retrospective analysis of the surgical outcome. The incidence was calculated to be 6.8 benign tumours in the parotid gland per 100,000 persons per year. The histological distribution showed a frequency of 54% pleomorphic adenomas, 28% adenolymphomas and 18% other tumours. In the observation period there was a 3% recurrence rate in our material, most frequently the pleomorphic adenoma. The risk of permanent damage to the facial nerve was 1% for severe injury and 3% for affection of the ramus marginalis. Frey's syndrome was present in 50% of the patients, moreover the syndrome was observed many years after surgery. The frequency rate reached its highest level about five years postoperatively.

摘要

在1986年至1995年的十年间,哥本哈根郡有433例患者因腮腺良性肿瘤接受手术。在本研究中,我们对手术结果进行了回顾性分析。发病率经计算为每年每10万人中有6.8例腮腺良性肿瘤。组织学分布显示,多形性腺瘤的发生率为54%,腺淋巴瘤为28%,其他肿瘤为18%。在观察期内,我们的资料中复发率为3%,最常见于多形性腺瘤。面神经严重损伤导致永久性损伤的风险为1%,边缘支受累的风险为3%。50%的患者出现了味觉出汗综合征,此外,该综合征在术后多年仍可观察到。发病率在术后约五年达到最高水平。

相似文献

1
[Benign neoplasms in the parotid gland in the county of Copenhagen 1986-1995].[1986 - 1995年哥本哈根县腮腺良性肿瘤]
Ugeskr Laeger. 1998 Oct 12;160(42):6066-9.
2
Complications of superficial parotidectomy versus extracapsular lumpectomy in the treatment of benign parotid lesions.浅叶腮腺切除术与囊外肿块切除术治疗腮腺良性病变的并发症
J R Coll Surg Edinb. 1992 Jun;37(3):155-8.
3
Risk of facial palsy and severe Frey's syndrome after conservative parotidectomy for benign disease: analysis of 610 operations.良性疾病行保守性腮腺切除术后发生面瘫和严重味觉出汗综合征的风险:610例手术分析
Acta Otolaryngol. 2006 Oct;126(10):1104-9. doi: 10.1080/00016480600672618.
4
[Salivary gland tumors in the County of Funen, 1984-2003].[1984年至2003年菲英岛县的唾液腺肿瘤]
Ugeskr Laeger. 2008 Feb 11;170(7):545-8.
5
Parotid surgery: review of 107 tumors (1990-2002).腮腺手术:107例肿瘤回顾(1990 - 2002年)
Int Surg. 2005 Jul-Aug;90(3):160-6.
6
[A 20-year retrospective histoclinical analysis of parotid gland tumors in the ENT Department AM in Katowice].[卡托维兹耳鼻喉科AM科室腮腺肿瘤的20年回顾性组织临床分析]
Otolaryngol Pol. 2007;61(4):399-403. doi: 10.1016/S0030-6657(07)70451-1.
7
Comprehensive analysis of parotid mass: A retrospective study of 369 cases.腮腺肿块的综合分析:369例回顾性研究。
Auris Nasus Larynx. 2018 Apr;45(2):320-327. doi: 10.1016/j.anl.2017.04.003. Epub 2017 May 1.
8
Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients.腮腺原发性良性多形性腺瘤的全腮腺保守切除术:229例患者的25年经验
Laryngoscope. 1994 Dec;104(12):1487-94. doi: 10.1288/00005537-199412000-00011.
9
[Our experience in the treatment of the tumors of parotid gland].[我们在腮腺肿瘤治疗方面的经验]
An Otorrinolaringol Ibero Am. 2007;34(3):257-71.
10
Analysis of complications following surgical treatment of benign parotid disease.腮腺良性疾病手术治疗后并发症分析
ANZ J Surg. 2008 Mar;78(3):134-8. doi: 10.1111/j.1445-2197.2007.04388.x.

引用本文的文献

1
Evaluation of Salivary Function Post-Partial Superficial Parotidectomy.腮腺浅叶部分切除术后唾液功能评估
Iran J Otorhinolaryngol. 2024 May;36(3):483-488. doi: 10.22038/IJORL.2024.76003.3551.
2
The distribution of parotid gland neoplasms in a veteran population.老兵群体中腮腺肿瘤的分布情况。
World J Otorhinolaryngol Head Neck Surg. 2020 Jul 8;7(4):285-290. doi: 10.1016/j.wjorl.2020.05.009. eCollection 2021 Oct.